“I am delighted to welcome Scott to the Vyriad team. His proven leadership and relentless focus on execution will help realize our Company’s goals,” said Dr. Stephen Russell, Vyriad’s Chief Executive Officer. vyriad.com/news/news-rele…

Welcome to Vyriad's newest Quality team members! #Vyriad #RochesterMN #NewEmployees #Biotechnology #hiring

Welcome to Vyriad's newest Manufacturing team members! #Vyriad #RochesterMN #NewEmployees #Biotechnology #hiring

Happy First Day of Fall from the team at Vyriad! #VyriadMN #FallinMN #RochesterMN #cancerresearch

Happy World Smile Day! 😊 𝑺𝒉𝒂𝒓𝒆 𝒚𝒐𝒖𝒓 𝒔𝒎𝒊𝒍𝒆 𝒘𝒊𝒕𝒉 𝒕𝒉𝒆 𝒘𝒐𝒓𝒍𝒅. . . . #ROCHESTERMN #VYRIAD #BIOTECH #MN #worldsmileday #wearyoursmile #shareyoursmile #oncologyresearch #smilemore

This month's Employee Spotlight: Lee Khang #Vyriad #EmployeeSpotlight #EmployeeAppreciation #Biotechnology #Oncolytic #Virotherapy #clinicaltrials #CancerResearch #Custodian #employeeengagement #RochesterMN #Minnesota

#employeespotlight #VyriadMN #rochestermn #virotherapy #cancerresearch

Here's to our hard-working bosses at Vyriad!! #NationalBossesDay #Vyriad #celebrateyourboss #biotech #rochestermn #minnesota

Oncolytic virotherapy trial shows early sign in Lymphoma. Read below: nam02.safelinks.protection.outlook.com/?url=http%3A%2…

#employeespotlight #VyriadMN #RochesterMN #cancerresearch

Thank you to all our Veterans! #veteransday #sacrifice #courage #honor #thankyou #vyriadmn #rochestermn #VeteransDay2022 #veterans

Happy Thanksgiving! Our office will be closed on Thanksgiving Day 11/24 and Friday 11/25.

Welcome to the Vyriad team, Kirstin. We are delighted to have you! #Vyriad #NewHire #EmployeeAppreciation #Biotechnology #Oncolytic #Virotherapy #clinicaltrials #CancerResearch #employeeengagement #RochesterMN #Minnesota

This month's Employee Spotlight: Linda Sarkar #Vyriad #EmployeeSpotlight #EmployeeAppreciation #Biotechnology #Oncolytic #Virotherapy #clinicaltrials #CancerResearch #Custodian #employeeengagement #RochesterMN #Minnesota #Quality

Merry Christmas and Happy New Year from Vyriad.

Vyriad Announces Oral Presentation at the 65th American Society of Hematology Annual Meeting Read more: prnewswire.com/news-releases/…

Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies. Read More: prn.to/4fQQolm

Thank you, @MegaDarren , and FierceBiotech for a good read! We look forward to progressing this new modality together. Read the article here: fiercebiotech.com/biotech/novart…

Curious about measles? Tune into this fascinating episode that sheds light on how it continues to shape public health today. A huge thank you to Pushkin Industries 🎙️ for bringing this insightful podcast to life! Listen here: lnk.to/UoyK0q

Vyriad to participate in upcoming investor conference next week, October 15th at H.C. Wainwright & Co. Genetic Medicines Virtual Conferences; holding 1x1 meetings #invivo #CART #cancerpatients #Vyriad #H.C. Wainright&CO.